IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 567.21M
Enterprise Value 39.25M
Trailing P/E N/A
Forward P/E 1-1.50
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)39.72
Price/Book (mrq)1.41
Enterprise Value/Revenue 35.47
Enterprise Value/EBITDA 6-0.19

Trading Information

Stock Price History

Beta (3Y Monthly) 2.82
52-Week Change 3-74.10%
S&P500 52-Week Change 31.31%
52 Week High 310.9500
52 Week Low 32.0800
50-Day Moving Average 32.4985
200-Day Moving Average 32.7028

Share Statistics

Avg Vol (3 month) 3262.27k
Avg Vol (10 day) 3183.38k
Shares Outstanding 5195.64M
Float 20.11M
% Held by Insiders 120.41%
% Held by Institutions 145.77%
Shares Short (Jul 31, 2019) 4924.53k
Short Ratio (Jul 31, 2019) 44.68
Short % of Float (Jul 31, 2019) 44.03%
Short % of Shares Outstanding (Jul 31, 2019) 43.21%
Shares Short (prior month Jun 28, 2019) 41.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3Jul 30, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-2,826.00%

Management Effectiveness

Return on Assets (ttm)-38.85%
Return on Equity (ttm)-69.13%

Income Statement

Revenue (ttm)1.69M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)788.30%
Gross Profit (ttm)-25.37M
EBITDA -47.64M
Net Income Avi to Common (ttm)-45.91M
Diluted EPS (ttm)-1.6610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.37M
Total Cash Per Share (mrq)1.82
Total Debt (mrq)189k
Total Debt/Equity (mrq)0.40
Current Ratio (mrq)8.19
Book Value Per Share (mrq)1.66

Cash Flow Statement

Operating Cash Flow (ttm)-46.59M
Levered Free Cash Flow (ttm)-30.51M